The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-(6-chloro-3-(3-(4-hydroxypiperidin-1-ylsulfonyl)-4-methoxyphenyl)-2-methylimidazo[1,2-b]pyridazin-8-ylamino)ethyl)acetamide ID: ALA3921556
PubChem CID: 134139703
Max Phase: Preclinical
Molecular Formula: C23H29ClN6O5S
Molecular Weight: 537.04
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(-c2c(C)nc3c(NCCNC(C)=O)cc(Cl)nn23)cc1S(=O)(=O)N1CCC(O)CC1
Standard InChI: InChI=1S/C23H29ClN6O5S/c1-14-22(30-23(27-14)18(13-21(24)28-30)26-9-8-25-15(2)31)16-4-5-19(35-3)20(12-16)36(33,34)29-10-6-17(32)7-11-29/h4-5,12-13,17,26,32H,6-11H2,1-3H3,(H,25,31)
Standard InChI Key: WAVAUTGKSRGNCM-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 39 0 0 0 0 0 0 0 0999 V2000
8.4705 -15.3390 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2600 -16.1315 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.0515 -15.9175 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2516 -14.4249 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.9524 -14.0132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9483 -13.1961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6532 -12.7845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6490 -11.9673 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9400 -11.5618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2350 -11.9734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5218 -11.5719 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5177 -10.7548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8045 -10.3492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2226 -10.3390 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6656 -14.4188 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3705 -14.0072 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3623 -13.1859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1410 -12.9275 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6237 -13.5900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4409 -13.5818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1461 -14.2540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4045 -15.0286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8629 -15.6406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1212 -16.4153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9213 -16.5779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1797 -17.3526 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6380 -17.9646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4630 -15.9660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5672 -16.8921 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2087 -15.1913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0595 -17.5329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3635 -18.2909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1756 -18.4095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6829 -17.7636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3781 -16.9991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4788 -19.1684 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
5 15 2 0
15 16 1 0
16 17 1 0
7 17 1 0
17 18 2 0
18 19 1 0
19 20 1 0
19 21 2 0
16 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 1 0
25 28 1 0
28 2 1 0
2 29 1 0
28 30 2 0
22 30 1 0
29 31 1 0
29 35 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
33 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 537.04Molecular Weight (Monoisotopic): 536.1609AlogP: 2.06#Rotatable Bonds: 8Polar Surface Area: 138.16Molecular Species: NEUTRALHBA: 9HBD: 3#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 3.20CX LogP: -0.12CX LogD: -0.12Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.37Np Likeness Score: -1.43
References 1. Mejdrová I, Chalupská D, Plačková P, Müller C, Šála M, Klíma M, Baumlová A, Hřebabecký H, Procházková E, Dejmek M, Strunin D, Weber J, Lee G, Matoušová M, Mertlíková-Kaiserová H, Ziebuhr J, Birkus G, Boura E, Nencka R.. (2017) Rational Design of Novel Highly Potent and Selective Phosphatidylinositol 4-Kinase IIIβ (PI4KB) Inhibitors as Broad-Spectrum Antiviral Agents and Tools for Chemical Biology., 60 (1): [PMID:28004945 ] [10.1021/acs.jmedchem.6b01465 ]